Treximet - Next-Generation Treatment for Migraine
Key Data:
Drug (brand / generic)
Treximet
Company / licensee
Pozen / GSK
Therapy class
NSAID / triptan combination
Product description
Sumatriptan plus naproxen sodium in a single tablet
Current indication
Acute migraine
Market sector
CNS, analgesics
Development status
Approved US
